Dr. Lea Hachmeister advises companies and investors in the healthcare and life sciences market, with a focus on pharmaceutical and medical device companies. She specializes on transactions and strategic cooperations in the health and life sciences sector, regulatory issues, such as market entry and reimbursement channels for drugs and medical devices, as well as industry-specific data protection and compliance issues.

Show More

Lea advised:

• Pharmaceutical companies, wholesalers, pharmacies and medical devices companies on issues of pricing, market access and reimbursement by public and private payers, and public procurement
• Pharmaceutical and medical device manufacturers as well as health insurers in the area of digital health
• A global internet company on telemedical business models in times of the COVID-19 crisis
• Pharmaceutical companies and medical device manufacturers on the design and conduct of clinical trials
• German and international pharmaceutical companies and medical devices manufacturers on the regulation of advertising and promotion of medicinal products and medical devices, as well as on compliance with national and European codes of conduct

• The Legal 500 EMEA, Recommended, Germany: Healthcare and Life Sciences, and Commercial Administrative Law, 2024

Education
Philipps-University Marburg, Dr. jur., 2021
Higher Regional Court of Frankfurt, Second State Exam, 2021
Additional Qualification in Pharmaceutical Law with Distinction, 2016
Philipps-University Marburg, First State Exam, 2016

Admissions
Germany

Languages
German
English